Matches in SemOpenAlex for { <https://semopenalex.org/work/W2165712074> ?p ?o ?g. }
- W2165712074 endingPage "2901" @default.
- W2165712074 startingPage "2895" @default.
- W2165712074 abstract "Objective— Overproduction of hepatic apolipoprotein B (apoB)-100 containing very low-density lipoprotein particles and intestinal apoB-48 containing chylomicrons contributes to hypertriglyceridemia seen in conditions such as obesity and insulin resistance. Some, but not all, preclinical and clinical studies have demonstrated that the polyphenol resveratrol ameliorates insulin resistance and hypertriglyceridemia. Here, we assessed intestinal and hepatic lipoprotein turnover, in humans, after 2 weeks of treatment with resveratrol (1000 mg daily for week 1 followed by 2000 mg daily for week 2) or placebo. Approach and Results— Eight overweight or obese individuals with mild hypertriglyceridemia were studied on 2 occasions, 4 to 6 weeks apart, after treatment with resveratrol or placebo in a randomized, double-blinded, crossover study. Steady-state lipoprotein kinetics was assessed in a constant fed state with a primed, constant infusion of deuterated leucine. Resveratrol treatment did not significantly affect insulin sensitivity (homeostasis model of assessment of insulin resistance), fasting or fed plasma triglyceride concentration. Resveratrol reduced apoB-48 production rate by 22% ( P =0.007) with no significant effect on fractional catabolic rate. Resveratrol reduced apoB-100 production rate by 27% ( P =0.02) and fractional catabolic rate by 26% ( P =0.04). Conclusions— These results indicate that 2 weeks of high-dose resveratrol reduces intestinal and hepatic lipoprotein particle production. Long-term studies are needed to evaluate the potential clinical benefits of resveratrol in patients with hypertriglyceridemia, who have increased concentrations of triglyceride-rich lipoprotein apoB-100 and apoB-48. Clinical Trial Registration— URL: www.clinicaltrials.gov . Unique identifier: NCT01451918." @default.
- W2165712074 created "2016-06-24" @default.
- W2165712074 creator A5021774415 @default.
- W2165712074 creator A5034414826 @default.
- W2165712074 creator A5052593999 @default.
- W2165712074 creator A5063930428 @default.
- W2165712074 creator A5071484843 @default.
- W2165712074 date "2013-12-01" @default.
- W2165712074 modified "2023-10-05" @default.
- W2165712074 title "High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men" @default.
- W2165712074 cites W1975462549 @default.
- W2165712074 cites W1977950670 @default.
- W2165712074 cites W1984225039 @default.
- W2165712074 cites W1998334660 @default.
- W2165712074 cites W2007032642 @default.
- W2165712074 cites W2011574523 @default.
- W2165712074 cites W2021976026 @default.
- W2165712074 cites W2022267544 @default.
- W2165712074 cites W2025050749 @default.
- W2165712074 cites W2028319504 @default.
- W2165712074 cites W2036747551 @default.
- W2165712074 cites W2049520707 @default.
- W2165712074 cites W2082707171 @default.
- W2165712074 cites W2097681801 @default.
- W2165712074 cites W2100377339 @default.
- W2165712074 cites W2103450921 @default.
- W2165712074 cites W2110774736 @default.
- W2165712074 cites W2117499294 @default.
- W2165712074 cites W2117879192 @default.
- W2165712074 cites W2120007830 @default.
- W2165712074 cites W2125121177 @default.
- W2165712074 cites W2133444149 @default.
- W2165712074 cites W2134775482 @default.
- W2165712074 cites W2138134399 @default.
- W2165712074 cites W2144770293 @default.
- W2165712074 cites W2146182381 @default.
- W2165712074 cites W2147053026 @default.
- W2165712074 cites W2149210921 @default.
- W2165712074 cites W2152036317 @default.
- W2165712074 cites W2158149431 @default.
- W2165712074 cites W2165722123 @default.
- W2165712074 cites W2171474087 @default.
- W2165712074 doi "https://doi.org/10.1161/atvbaha.113.302342" @default.
- W2165712074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24072699" @default.
- W2165712074 hasPublicationYear "2013" @default.
- W2165712074 type Work @default.
- W2165712074 sameAs 2165712074 @default.
- W2165712074 citedByCount "87" @default.
- W2165712074 countsByYear W21657120742014 @default.
- W2165712074 countsByYear W21657120742015 @default.
- W2165712074 countsByYear W21657120742016 @default.
- W2165712074 countsByYear W21657120742017 @default.
- W2165712074 countsByYear W21657120742018 @default.
- W2165712074 countsByYear W21657120742019 @default.
- W2165712074 countsByYear W21657120742020 @default.
- W2165712074 countsByYear W21657120742021 @default.
- W2165712074 countsByYear W21657120742022 @default.
- W2165712074 countsByYear W21657120742023 @default.
- W2165712074 crossrefType "journal-article" @default.
- W2165712074 hasAuthorship W2165712074A5021774415 @default.
- W2165712074 hasAuthorship W2165712074A5034414826 @default.
- W2165712074 hasAuthorship W2165712074A5052593999 @default.
- W2165712074 hasAuthorship W2165712074A5063930428 @default.
- W2165712074 hasAuthorship W2165712074A5071484843 @default.
- W2165712074 hasBestOaLocation W21657120741 @default.
- W2165712074 hasConcept C11772777 @default.
- W2165712074 hasConcept C126322002 @default.
- W2165712074 hasConcept C134018914 @default.
- W2165712074 hasConcept C2776816829 @default.
- W2165712074 hasConcept C2776919658 @default.
- W2165712074 hasConcept C2777391703 @default.
- W2165712074 hasConcept C2778163477 @default.
- W2165712074 hasConcept C2778913445 @default.
- W2165712074 hasConcept C2779306644 @default.
- W2165712074 hasConcept C2780072125 @default.
- W2165712074 hasConcept C2911022245 @default.
- W2165712074 hasConcept C62746215 @default.
- W2165712074 hasConcept C71924100 @default.
- W2165712074 hasConcept C8243546 @default.
- W2165712074 hasConcept C98274493 @default.
- W2165712074 hasConceptScore W2165712074C11772777 @default.
- W2165712074 hasConceptScore W2165712074C126322002 @default.
- W2165712074 hasConceptScore W2165712074C134018914 @default.
- W2165712074 hasConceptScore W2165712074C2776816829 @default.
- W2165712074 hasConceptScore W2165712074C2776919658 @default.
- W2165712074 hasConceptScore W2165712074C2777391703 @default.
- W2165712074 hasConceptScore W2165712074C2778163477 @default.
- W2165712074 hasConceptScore W2165712074C2778913445 @default.
- W2165712074 hasConceptScore W2165712074C2779306644 @default.
- W2165712074 hasConceptScore W2165712074C2780072125 @default.
- W2165712074 hasConceptScore W2165712074C2911022245 @default.
- W2165712074 hasConceptScore W2165712074C62746215 @default.
- W2165712074 hasConceptScore W2165712074C71924100 @default.
- W2165712074 hasConceptScore W2165712074C8243546 @default.
- W2165712074 hasConceptScore W2165712074C98274493 @default.
- W2165712074 hasIssue "12" @default.
- W2165712074 hasLocation W21657120741 @default.
- W2165712074 hasLocation W21657120742 @default.